ARTIDIS AG has developed first nanomechnical biomarker for rapid cancer diagnostics that in combination with powerful data analytics allows for improving patient`s treatment outcomes.
Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.